Abstract
Introduction: Myelodysplastic syndrome (MDS) is a clonal hematopoietic disorder with a risk of progression to acute myeloid leukaemia. This case report discusses a rare instance of spontaneous splenic rupture in a patient with MDS. Case Report: A 76-year-old male with a history of MDS presented with acute abdominal pain and was found to have a splenic rupture. Despite declining chemotherapy, the patient underwent an emergency splenectomy after a CT scan revealed hemoperitoneum. Post-surgery, the patient experienced hypovolemic shock, necessitating a second operation. Discussion: Splenic rupture in MDS is uncommon and its pathogenesis is not fully understood. Management of MDS is complex, often requiring a multidisciplinary approach. This case emphasizes the importance of considering patient preferences in treatment decisions and highlights the role of next-generation sequencing in understanding MDS pathogenesis. Conclusion: The case underscores the need for vigilance in managing MDS due to potential complications like splenic rupture. It also illustrates the importance of personalized care and advances in genetic profiling in predicting prognosis and guiding treatment in MDS.
Publisher
Universidad de Iberoamerica
Reference14 articles.
1. Síndromes mielodisplásicos: una actualización para el médico no hematólogo – Medicina Interna de México [Internet]. [citado 15 de enero de 2024]. Disponible en: https://medicinainterna.org.mx/article/sindromes-mielodisplasicos-una-actualizacion-para-el-medico-no-hematologo/
2. Pulgarin JCC, Franco OA, Orduz YR. Síndrome mielodisplásico: aspectos básicos y abordaje diagnóstico. Revista Colombiana de Hematología y Oncología. 1 de octubre de 2021;8(1):90-106.
3. Duarte Pérez Y, Triana Marrero Y, Marsán Suárez V, Duarte Pérez Y, Triana Marrero Y, Marsán Suárez V. Síndromes mielodisplásicos y sistema inmunitario. Revista Cubana de Hematología, Inmunología y Hemoterapia [Internet]. marzo de 2021 [citado 15 de enero de 2024];37(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S0864-02892021000100013&lng=es&nrm=iso&tlng=es
4. Cluzeau T. Síndromes mielodisplásicos. EMC - Tratado de Medicina. 1 de noviembre de 2020;24(4):1-7.
5. Cells | Free Full-Text | The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications [Internet]. [citado 15 de enero de 2024]. Disponible en: https://www.mdpi.com/2073-4409/9/11/2512